| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 01/24/2008 | WO2008010578A1 Process for production of styrene derivative |
| 01/24/2008 | WO2008010433A1 Bridged cyanine compounds and optical recording materials containing the same |
| 01/24/2008 | WO2007126957A3 New compounds |
| 01/24/2008 | US20080021079 Compounds, Compositions, and Methods |
| 01/23/2008 | EP1879564A2 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 01/23/2008 | CN101111486A 抗糖尿病二环化合物 Antidiabetic bicyclic compound |
| 01/23/2008 | CN101111485A New haloalkylsulfonanilide derivative, herbicide and use method thereof |
| 01/23/2008 | CN101108832A Five member ring heterocyclic compound, process for producing the same and application thereof |
| 01/23/2008 | CN100363361C Hetaryl-substd. heterocycles |
| 01/22/2008 | US7321063 Sulfonamide inhibitors of aspartyl protease |
| 01/22/2008 | US7320978 Inflammations of the respiratory system, locomotor system traumas, and edemas; 1-{[5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1,3-oxazol-2-yl]carbonyl}-4-(3-methylphenyl)piperazine |
| 01/22/2008 | US7320867 Linker compound, ligand, and producing method thereof |
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/17/2008 | WO2007019080A3 Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2008 | WO2005066120A3 Process for asymmetric synthesis of hydroxy-alkyl substituted azetidinone derivatives |
| 01/17/2008 | US20080015357 Process for the preparation of boronic acids and derivatives |
| 01/17/2008 | US20080015238 Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 01/17/2008 | US20080015237 New compounds i/418 |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015193 Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/16/2008 | EP1644320B1 Indane derivates as muscarinic receptor agonists |
| 01/15/2008 | US7319152 5-Aryl-indan-1-one and analogs useful as progesterone receptor modulators |
| 01/15/2008 | US7319150 Method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 01/15/2008 | US7319104 hPPARs activators |
| 01/15/2008 | US7319099 Benzoyl-piperazine derivatives |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | US7318966 Luminescent element material and luminescent element comprising the same |
| 01/13/2008 | CA2593557A1 Process for the preparation of boronic acids and derivatives thereof |
| 01/10/2008 | WO2008006096A1 Metaxalone synthesis |
| 01/10/2008 | WO2008006044A2 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | WO2008006043A2 1,3-oxazole derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents |
| 01/10/2008 | WO2007123853A3 Five-membered heterocyclic invertebrate pest control agents |
| 01/10/2008 | WO2007093292A3 Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009534 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/10/2008 | US20080009533 Glycine, N-[[3-[[2-(4-chlorophenyl)-5-methyl-4-oxazolyl]methoxy]phenyl]methyl]-N-(methoxycarbonyl)-, used for treating atherosclerosis, dyslipidemia, diabetes, non-insulin dependent diabetes, hyperglycemia, hyperinsulinemia and obesity |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009520 Benzimidazolidinone derivatives as muscarinic agents |
| 01/10/2008 | US20080009506 Imidazole Compound |
| 01/10/2008 | US20080006797 Photochromic compound and optical functional material |
| 01/09/2008 | EP1874776A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders |
| 01/09/2008 | EP1874764A2 Imino-oxazolidines and use thereof as anticoagulants |
| 01/09/2008 | EP1874745A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands |
| 01/09/2008 | EP1874742A1 3,4-dihydro-benzo[e][1,3]oxazin-2-ones |
| 01/09/2008 | EP1874305A2 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 01/09/2008 | EP1660466B1 Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | CN101103018A Compounds for the treatment of CNS and amyloid associated diseases |
| 01/09/2008 | CN101103003A Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMS) |
| 01/09/2008 | CN100360525C Novel oxazolidone derivative, its preparing method and use |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317030 Compounds as inhibitors of cell proliferation and viral infections |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317024 Obesity, diabetes, inflammatory and immune diseases |
| 01/03/2008 | WO2008002570A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004451 Pseudo proline dipeptides |
| 01/03/2008 | US20080004450 cyclization; deprotecting; treatment of cancer and cancer which has developed multidrug-resistant phenotype |
| 01/03/2008 | US20080004440 Scar treatment using protein phosphatase inhibitors |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | CA2657107A1 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/02/2008 | EP1871749A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 01/02/2008 | EP1656361B1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 01/02/2008 | CN101098862A New 3-phenylpropionic acid derivatives and their use as ppar-gamma rezeptor liganden |
| 01/02/2008 | CN101098846A Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 01/02/2008 | CN101098845A 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 01/02/2008 | CN101098844A Phenylbenzoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 01/02/2008 | CN101098698A 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
| 12/27/2007 | WO2007149543A2 Scar treatment using protein phosphatase inhibitors |
| 12/27/2007 | WO2007149395A2 2,5-substituted oxazole derivatives as protein kinase inhibitors for the treatment of cancer |
| 12/27/2007 | WO2007148808A1 Tricyclic compound and pharmaceutical use thereof |
| 12/27/2007 | WO2007148089A2 Radiolabelling methods |
| 12/27/2007 | WO2007147336A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents |
| 12/27/2007 | WO2007047306A8 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 12/27/2007 | WO2004058735A3 Ligands of melanocortin receptors and compositions and methods related thereto |
| 12/27/2007 | US20070299118 Benzoxazolone Derivatives, Processes For Preparing Them And Their Uses |
| 12/27/2007 | US20070299117 Hydroxypropylaimines |
| 12/27/2007 | US20070299114 Biaryl Derivatives |
| 12/27/2007 | US20070299077 Aryl-substituted polycyclic amines, method for the production thereof, and use thereof as a medicament |
| 12/27/2007 | US20070299074 Guanidine Compounds, and Use Thereof as Binding partners for 5-Ht5 Receptors |
| 12/27/2007 | CA2655753A1 Tricyclic compound and pharmaceutical use thereof |
| 12/26/2007 | EP1597248B1 Sulfonamide derivatives as ppar modulators |
| 12/26/2007 | EP0804428B1 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 12/26/2007 | CN101094843A Insecticidal 3-(dihaloalkenyl)phenyl derivatives |
| 12/26/2007 | CN101092400A 黄嘌呤氧化酶抑制剂 Xanthine oxidase inhibitors |
| 12/26/2007 | CN100357283C Methionyl aminopeptidase inhibitor |
| 12/26/2007 | CN100357280C Dihydronaphthalene devivatives and drugs contanining these compounds as active ingrdeient |
| 12/26/2007 | CN100356917C Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 12/25/2007 | US7312360 Substituted hydroxyethylamines |
| 12/25/2007 | US7312339 cytotoxic agents; made by fermentation of Streptomyces sparsogenes |
| 12/25/2007 | US7312338 use treating peroxysome proliferator-activated receptor gamma (PPAR gamma ) mediated diseases and conditions such as diabetes, insulin resistance; e.g. 2-(1,3-benzoxazol-2-ylamino)-3-(4-(2,3-dihydro-1,4-benzodioxin-6-ylmethoxy)phenyl)propionic acid |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/20/2007 | US20070293542 Selective Cox-2 Inhibitors |
| 12/20/2007 | US20070293540 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 12/20/2007 | US20070293495 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine |
| 12/20/2007 | US20070293487 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 12/20/2007 | US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 12/19/2007 | EP1866295A2 Processes for the preparation of linezolid intermediate |
| 12/19/2007 | EP1866294A1 Compounds comprising an oxazoline or thiazoline moiety, processes for making them, and their uses |
| 12/19/2007 | EP1866293A1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |